ArticleJournal of Cancer2025

Multi-Omics Profiling Identifies a High-Risk Subgroup of Breast Cancer Stem Cells for Prognostic Stratification and Personalized Treatment.

Guixin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.